Variant report
Variant | nsv1009850 |
---|---|
Chromosome Location | chr2:76924371-76949552 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs370139428 | chr2:76924376-76924377 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs180986816 | chr2:76924378-76924379 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs184137572 | chr2:76924414-76924415 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs533967311 | chr2:76924454-76924455 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs548971603 | chr2:76924459-76924460 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs552559676 | chr2:76924475-76924476 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs150635721 | chr2:76924482-76924483 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs189780748 | chr2:76924501-76924502 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs138741754 | chr2:76924510-76924511 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs538510794 | chr2:76924521-76924522 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs374858276 | chr2:76924557-76924558 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs571504579 | chr2:76924602-76924603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs367906866 | chr2:76924632-76924633 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs181609384 | chr2:76924651-76924652 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs553934426 | chr2:76924666-76924667 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs186790260 | chr2:76924678-76924679 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs11695613 | chr2:76924679-76924680 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs368242212 | chr2:76924688-76924689 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs190502839 | chr2:76924696-76924697 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs549109508 | chr2:76924716-76924717 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs181955233 | chr2:76924718-76924719 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs11695530 | chr2:76924724-76924725 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs186384283 | chr2:76924739-76924740 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs189655972 | chr2:76924747-76924748 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs62170373 | chr2:76924757-76924758 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs115782999 | chr2:76924766-76924767 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs572988107 | chr2:76924784-76924785 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs527650135 | chr2:76924802-76924803 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs533685559 | chr2:76924813-76924814 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs557300872 | chr2:76924822-76924823 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs567407228 | chr2:76924831-76924832 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs558503151 | chr2:76924834-76924835 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs531624551 | chr2:76924846-76924847 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs146400551 | chr2:76924849-76924850 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs182341293 | chr2:76924852-76924853 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs571012414 | chr2:76924880-76924881 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs139735535 | chr2:76924891-76924892 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs553866759 | chr2:76924892-76924893 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs565785467 | chr2:76924895-76924896 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs144413278 | chr2:76924926-76924927 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs369875916 | chr2:76925002-76925003 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs62170374 | chr2:76925017-76925018 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs186553783 | chr2:76925049-76925050 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs562454006 | chr2:76925099-76925100 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs144360267 | chr2:76925108-76925109 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs556620322 | chr2:76925129-76925130 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs148770122 | chr2:76925132-76925133 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs191205779 | chr2:76925137-76925138 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs183505354 | chr2:76925139-76925140 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs527789298 | chr2:76925149-76925150 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Lung cancer | 18438408 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Mental retardation | 17124404 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Cancer | 17440070 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Breast cancer | 16272173 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Breast cancer | 22522925 | CNVD |
Epilepsy | 22083797 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:76906000-76926600 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
2 | chr2:76916000-76927800 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
3 | chr2:76918600-76927600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
4 | chr2:76925600-76925800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr2:76926600-76926800 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
6 | chr2:76927800-76928400 | Strong transcription | HUES6 Cell Line | embryonic stem cell |
7 | chr2:76928000-76928400 | Enhancers | Fetal Heart | heart |
8 | chr2:76928400-76934800 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
9 | chr2:76934800-76935200 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
10 | chr2:76934800-76936000 | ZNF genes & repeats | HUES6 Cell Line | embryonic stem cell |
11 | chr2:76935200-76949800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
12 | chr2:76936000-76938600 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
13 | chr2:76937000-76937200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
14 | chr2:76938400-76939000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
15 | chr2:76938400-76939400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
16 | chr2:76938600-76939000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
17 | chr2:76938600-76939200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
18 | chr2:76939000-76947800 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
19 | chr2:76944000-76944200 | Enhancers | Pancreatic Islets | Pancreatic Islet |